Nektar Therapeutics

Nektar is a clinical-stage biopharmaceutical company developing a pipeline of drug candidates designed to improve the benefits of drugs for patients.

Founded

1990

Raised

$45M

Follow us

Also headquartered in San Francisco

Companies in the same industry

Built with ❤︎ by Datalicious ©2019
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Add info

Add round

03 Jul 2008

$18,000,000

Venture capital (Series A)

New Leaf Venture Partners, Clarus Ventures, 5AM Ventures, +1